Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Autoimmune Diseases × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 10 Psoriasis 5 Leukemia 5 Myelodysplastic Syndromes 3 Lymphoma, Follicular 3 Inflammation 3 Asthma 3 Arthritis, Juvenile 3 Vasculitis 2 Uveitis 2 Prostatic Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Granulomatosis with Polyangiitis 2 Wilms Tumor 1 Temporomandibular Joint Disorders 1 Stomatitis 1 Spondylitis, Ankylosing 1 Respiratory Distress Syndrome 1 Recurrence 1 Pruritus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia 1 Plaque, Amyloid 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

telitacicept 3 fludarabine 3 Prednisone 3 Cyclophosphamide 3 Specimen Handling 2 Nivolumab 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Vitamin D 1 Valsartan 1 Pyridostigmine Bromide 1 Population Groups 1 Plasma Exchange 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Melphalan 1 Infliximab 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Fish Oils 1 Fatty Acids, Omega-3 1 Etoposide 1 Etanercept 1 Eicosapentaenoic Acid 1 Docosahexaenoic Acids 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡